FDA Finds New Data Linking Bad Heparin To China
Dr. Janet Woodcock, the director of the FDA's Center for Drug Evaluation and Research, said on Monday that a contaminant in the heparin batches was traced to 12 different Chinese companies. The batches were shipped to 11 nations.
The FDA pointed to over-sulfated chondroitin sulfate as the root cause of the adverse reactions. The...
To view the full article, register now.